Direct PeptidesProduct page includes use or preparation wordingIn stock
AOD-9604 · 5 mg × 10 vials
$709.00$14.18 / mg
Checked · 5 days ago
Lab report: Not linked
View product details (opens in a new tab)No commercial relationship
Research listings · Peptides
AOD-9604 research listings: prices and suppliers
Research materials and consumer products belong to different categories. A listing, laboratory report, or research-use label does not establish suitability for personal use.
We have no commercial relationship with suppliers on this page. Offers are sorted by price per mg; commission never changes the order.
Prices observed weekly · last check · How we check prices →
Lowest current at 5 mg × 10 vials$14.18 / mg · $709.00Direct Peptides · checked 5 days ago
Listings at 5 mg × 10 vials
| Supplier link | |||||||
|---|---|---|---|---|---|---|---|
| Direct PeptidesProduct page includes use or preparation wording | 5 mg × 10 vials | $709.00 | $14.18 / mg | In stock | 5 d ago | Not linked | View product details (opens in a new tab)No commercial relationship |
- Prices exclude shipping. A matching name does not verify the contents of a lot.
- Lab reports are vendor-reported, not independently authenticated. “Lab confirmed” means the issuing laboratory confirmed the report is theirs.
- Some suppliers’ product pages include use or preparation wording. We list their prices for comparison only; we do not endorse that wording, and nothing on this site is guidance on preparing or using these materials.
By size
Every package size we track for AOD-9604. Current means seen in the last 8 days.
| 2 mg × 1 vial | $30.00 | $15.00 / mg | 1 / 2 | 1 |
|---|---|---|---|---|
| 5 mg × 1 vial | $35.99 | $7.20 / mg | 8 / 10 | 8 |
| 10 mg × 1 vial | $80.00 | $8.00 / mg | 1 / 2 | 1 |
| 5 mg × 10 vials | $709.00 | $14.18 / mg | 1 / 1 | 1 |
Research context
From our own records, with the date each was last checked.
- FDA approval
- No approved drug product with this ingredient listed in Drugs@FDA (data updated 2026-11-02)Checked
- 503A / 503B compounding
- Formerly 503A category 2; nominations withdrawn. Not in any 503A category on FDA's 2026-05-14 listChecked
- Advisory committee (PCAC)
- PCAC voted 0 yes, 12 no on placing AOD-9604 (free base and acetate) on the 503A list (use reviewed: obesity)Checked
- Rulemaking / enforcement
- No proposed or final rule found in the Federal Register (search on 2026-11-03); the only match is FDA's 2024 PCAC meeting noticeChecked
- WADA
- S2.2.3 Growth hormone (GH), its analogues and fragments · Prohibited at all times — in and out of competition (2026 list; unchanged in the 2027 list, in force from Jan 1, 2027)Checked
- Identity
- Formula C78H123N23O23S2 · MW 1815.1 g/mol · CAS 221231-10-3Sequence YLRIVQCRSVEGSCGF (disulfide bond between Cys7 and Cys14)Source record Checked
Identity noteDiffers from HGH Fragment 176-191 in its first amino acid (tyrosine, not phenylalanine), so the two are tracked separately. FDA's substance registry also lists it as LAT-8881.
How we check prices · Offers are matched to our catalogue by an editor before they appear; a listing is not an endorsement.